Scope

Scope

Scope was established in 2017 by Fareed Bilbeisi, who serves as CEO of Scope Investment LLC, and is now overseen by CEO Ali al Ghanim alongside external specialists. The firm operates from Riyadh with additional offices in Dubai, Ljubljana, and Beirut. Its founding ties include Bilbeisi’s prior role as Group CFO of National Holding LLC, a frequent co-investor on regional projects. The group's deployment mixes direct real estate development, healthcare joint ventures, and industrial project management. Real estate assets include the Stella Maris residential tower in Dubai Marina, the Bloom Heights mixed-use project in Jumeirah Village Circle, and the At 85 Residences in Wasl Gate. Healthcare investments are structured through joint ventures with Asan Medical Center, which partnered on the Asan GI Hospital in Dubai Healthcare City, and with Barraquer Eye Hospital, also in Dubai Healthcare City. The firm has also backed the Vacsera syringe manufacturing project in Egypt alongside Exeed Industries, and it promotes smart-city infrastructure in Central Africa. Scope's own operations span general contracting, elevators through Al Falak Elevators, and mobile industrial units via Enntris. Scope's team size remains undisclosed. The firm belongs to the Middle East Council of Shopping Centres & Retailers and maintains a support relationship with the National Art Expressions initiative. Direct engagement with projects defines its operating model, with the firm stating that direct contact is more trustworthy than social marketing or self-advertisement. Scope is structured as a hybrid operator rather than a pure allocator: it builds, co-develops, and runs the companies it invests in, often alongside established regional partners such as National Holding and Al Mansour Automotive. This hands-on posture — spanning construction, healthcare, and industrial manufacturing across the Gulf and beyond — distinguishes it from a traditional family office or fund manager.